$ARNA Recent News Arena shares surge as marketer
Post# of 5326
Posted On: 11/08/2013 7:05:22 PM
$ARNA Recent News
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Apple, Arena active; Lumber Liquidators at new high 9:06 a.m. July 25, 2012 - blogs.marketwatch.com
Arena Pharma Q3 Loss Narrower than Expected - Analyst Blog 5:00 p.m. Today - Zacks.com
U.S. Judge Orders Ex-Morgan Staney Adviser to Return Data and 2 Heavily Traded Stocks to Follow 3:59 p.m. Today - Wall St. Cheat Sheet
VIVUS Loss In Line with Ests, Shares Fall - Analyst Blog 4:45 p.m. Nov. 7, 2013 - Zacks.com
Arena Pharmaceuticals, Eisai Expand Marketing and Supply Agreement for BELVIQ 3:03 p.m. Nov. 7, 2013 - benzinga.com
Arena's Belviq Refills - Week 20 12:43 a.m. Nov. 5, 2013 - Seeking Alpha
Arena Pharmaceuticals - Belviq OTC? 3:09 a.m. Nov. 4, 2013 - Seeking Alpha
Arena's Belviq - Week 20 Sales Data 1:28 p.m. Nov. 1, 2013 - Seeking Alpha
Arena Stock Reacts To Eisai Quarterly Call 10:26 a.m. Nov. 1, 2013 - Seeking Alpha
Should You Worry About the Short Interest in Arena Pharmaceuticals, Inc. (ARNA)? - Tale of the Tape 9:59 a.m. Nov. 1, 2013 - Zacks.com
Benzinga's Top #PreMarket Losers 7:13 a.m. Nov. 1, 2013 - benzinga.com
Uh Oh Arena Pharma! Q3 Belviq Sales Just $4.8M 7:09 a.m. Nov. 1, 2013 - TheStreet.com
A Look Back At Biotech Short Picks 2:18 p.m. Oct. 31, 2013 - Seeking Alpha
Interesting ARNA Put And Call Options For December 6th 10:46 a.m. Oct. 31, 2013 - TheStreet.com
Arena's Belviq Refills Week 19 3:29 a.m. Oct. 30, 2013 - Seeking Alpha
Latent Disconnect Between Arena's Fundamentals And Valuation 3:33 p.m. Oct. 29, 2013 - Seeking Alpha
Arena's Belviq Sales: Week 19 11:19 a.m. Oct. 25, 2013 - Seeking Alpha
November 29th Options Now Available For Arena Pharmaceuticals (ARNA) 11:15 a.m. Oct. 24, 2013 - TheStreet.com
Arena's Belviq Refills - Week 18 Data 4:26 p.m. Oct. 22, 2013 - Seeking Alpha
Arena's Belviq Sales Flat - Equity Holds 11:11 a.m. Oct. 18, 2013 - Seeking Alpha
Arena Pharmaceuticals, Inc. Enters Oversold Territory - Tale of the Tape 6:01 a.m. Oct. 18, 2013 - Zacks.com
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - PR Newswire
Arena Pharmaceuticals and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide 4:02 p.m. Nov. 7, 2013 - PR Newswire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
Must Watch Stock News: Arena Pharmaceuticals, Hewlett-Packard Company, Resorts International, Alpha Natural Resources, Chevron Corporation 1:56 p.m. Nov. 4, 2013 - PR Newswire
Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc. 9:00 a.m. Oct. 31, 2013 - PR Newswire
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7 8:00 a.m. Oct. 30, 2013 - PR Newswire
Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros 8:00 a.m. Oct. 21, 2013 - PR Newswire
Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December 9:03 a.m. Oct. 15, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. 9:26 a.m. Oct. 8, 2013 - PR Newswire
Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta 8:00 a.m. Sept. 25, 2013 - PR Newswire
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 8:00 a.m. Sept. 23, 2013 - PR Newswire
Arena Pharmaceuticals to Present Clinical Data for BELVIQ® (lorcaserin HCl) CIV at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) 8:00 a.m. Sept. 18, 2013 - PR Newswire
Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ® (lorcaserin HCl) CIV Enters Consumer Phase 8:00 a.m. Sept. 16, 2013 - PR Newswire
Track Insider Trading in Facebook, Zynga, Arena Pharmaceuticals, Lululemon Athletica, Weatherford International, and Bank of America 8:55 a.m. Sept. 13, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference 8:00 a.m. Sept. 6, 2013 - PR Newswire
Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation 8:00 a.m. Sept. 3, 2013 - PR Newswire
Five Star Equities Issues New Research Reports on ARNA, COCO, CWST and GES 8:40 a.m. Aug. 30, 2013 - ACCESSWIRE
Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension 8:00 a.m. Aug. 28, 2013 - PR Newswire
Innovus Pharma Provides Corporate Update 6:30 a.m. Aug. 19, 2013 - GlobeNewswire
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Apple, Arena active; Lumber Liquidators at new high 9:06 a.m. July 25, 2012 - blogs.marketwatch.com
Arena Pharma Q3 Loss Narrower than Expected - Analyst Blog 5:00 p.m. Today - Zacks.com
U.S. Judge Orders Ex-Morgan Staney Adviser to Return Data and 2 Heavily Traded Stocks to Follow 3:59 p.m. Today - Wall St. Cheat Sheet
VIVUS Loss In Line with Ests, Shares Fall - Analyst Blog 4:45 p.m. Nov. 7, 2013 - Zacks.com
Arena Pharmaceuticals, Eisai Expand Marketing and Supply Agreement for BELVIQ 3:03 p.m. Nov. 7, 2013 - benzinga.com
Arena's Belviq Refills - Week 20 12:43 a.m. Nov. 5, 2013 - Seeking Alpha
Arena Pharmaceuticals - Belviq OTC? 3:09 a.m. Nov. 4, 2013 - Seeking Alpha
Arena's Belviq - Week 20 Sales Data 1:28 p.m. Nov. 1, 2013 - Seeking Alpha
Arena Stock Reacts To Eisai Quarterly Call 10:26 a.m. Nov. 1, 2013 - Seeking Alpha
Should You Worry About the Short Interest in Arena Pharmaceuticals, Inc. (ARNA)? - Tale of the Tape 9:59 a.m. Nov. 1, 2013 - Zacks.com
Benzinga's Top #PreMarket Losers 7:13 a.m. Nov. 1, 2013 - benzinga.com
Uh Oh Arena Pharma! Q3 Belviq Sales Just $4.8M 7:09 a.m. Nov. 1, 2013 - TheStreet.com
A Look Back At Biotech Short Picks 2:18 p.m. Oct. 31, 2013 - Seeking Alpha
Interesting ARNA Put And Call Options For December 6th 10:46 a.m. Oct. 31, 2013 - TheStreet.com
Arena's Belviq Refills Week 19 3:29 a.m. Oct. 30, 2013 - Seeking Alpha
Latent Disconnect Between Arena's Fundamentals And Valuation 3:33 p.m. Oct. 29, 2013 - Seeking Alpha
Arena's Belviq Sales: Week 19 11:19 a.m. Oct. 25, 2013 - Seeking Alpha
November 29th Options Now Available For Arena Pharmaceuticals (ARNA) 11:15 a.m. Oct. 24, 2013 - TheStreet.com
Arena's Belviq Refills - Week 18 Data 4:26 p.m. Oct. 22, 2013 - Seeking Alpha
Arena's Belviq Sales Flat - Equity Holds 11:11 a.m. Oct. 18, 2013 - Seeking Alpha
Arena Pharmaceuticals, Inc. Enters Oversold Territory - Tale of the Tape 6:01 a.m. Oct. 18, 2013 - Zacks.com
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - PR Newswire
Arena Pharmaceuticals and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide 4:02 p.m. Nov. 7, 2013 - PR Newswire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
Must Watch Stock News: Arena Pharmaceuticals, Hewlett-Packard Company, Resorts International, Alpha Natural Resources, Chevron Corporation 1:56 p.m. Nov. 4, 2013 - PR Newswire
Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc. 9:00 a.m. Oct. 31, 2013 - PR Newswire
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7 8:00 a.m. Oct. 30, 2013 - PR Newswire
Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros 8:00 a.m. Oct. 21, 2013 - PR Newswire
Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December 9:03 a.m. Oct. 15, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. 9:26 a.m. Oct. 8, 2013 - PR Newswire
Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta 8:00 a.m. Sept. 25, 2013 - PR Newswire
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 8:00 a.m. Sept. 23, 2013 - PR Newswire
Arena Pharmaceuticals to Present Clinical Data for BELVIQ® (lorcaserin HCl) CIV at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) 8:00 a.m. Sept. 18, 2013 - PR Newswire
Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ® (lorcaserin HCl) CIV Enters Consumer Phase 8:00 a.m. Sept. 16, 2013 - PR Newswire
Track Insider Trading in Facebook, Zynga, Arena Pharmaceuticals, Lululemon Athletica, Weatherford International, and Bank of America 8:55 a.m. Sept. 13, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference 8:00 a.m. Sept. 6, 2013 - PR Newswire
Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation 8:00 a.m. Sept. 3, 2013 - PR Newswire
Five Star Equities Issues New Research Reports on ARNA, COCO, CWST and GES 8:40 a.m. Aug. 30, 2013 - ACCESSWIRE
Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension 8:00 a.m. Aug. 28, 2013 - PR Newswire
Innovus Pharma Provides Corporate Update 6:30 a.m. Aug. 19, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼